Science Press Releases: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Science Press Releases.

Press releases published on August 14, 2026

Nexera: Subsidiary Fort Technology Reports Record First Half of 2026 Results with 49% Revenue Growth to $7.36 Million and 145% Increase in Gross Profit Year over Year and Expanding to Solutions for Data Centers
Trident Digital Tech Joint Venture Projects Sikaflow Revenue Run-Rate of Approximately US$65 Million Annualized Exiting 2026
Safe Pro Reports Record 1,336% Revenue Growth in Q2 2026 Driven by Multiple Government Contracts for AI-Powered Threat Detection and Mapping
Evaxion to announce business update and second quarter 2026 financial results on August 20, 2026
PMV Pharmaceuticals Reports Second Quarter 2026 Financial Results and Corporate Highlights
GT Biopharma Reports Second Quarter 2026 Financial Results
Lantheus Announces FDA Approval of TAUKLARIFY™ (Florquinitau F 18 Injection), an F18-Labeled Tau PET Imaging Agent for Alzheimer’s Disease
CSPi Reports FY2026 Third Quarter Results
Annovis Provides Corporate Updates and Second Quarter 2026 Financial Results
Replimune Reports Fiscal First Quarter 2027 Financial Results and Provides Corporate Update
Diamond Equity Research Releases Update Note on Almonty Industries, Inc. (Nasdaq: ALM; Frankfurt: ALI1)
Counter Drone Market to Reach USD 29.70 Billion by 2031, Growing at 26.5% CAGR, Says MarketsandMarkets™
Quince Therapeutics Reports Second Quarter 2026 Financial Results and Corporate Update
Indiana Center for Recovery Named No. 1 Addiction Treatment Center in Indiana by Newsweek
How Appinventiv is Solving AI Adoption Challenges for Global Enterprises
BridgeBio Pharma Announces Pricing of Oversubscribed Secondary Offering that Diversifies its Institutional Shareholder Base
Diginex Limited Announces Extraordinary General Meeting to Approve Proposed Acquisition of Resulticks
WRAP Selected by WOFT to Support Florida’s $475,000 Teacher Safety Training Initiative
Outlook Therapeutics Reports Third Quarter Fiscal Year 2026 Financial Results and Provides Business Update Highlighting FDA Approval of LYTENAVA™
Tvardi Therapeutics Announces Second Quarter 2026 Results and Provides Business Update

Share this page:

Advanced Search Options

Search for:

Search scope:

Type:

Search in:

Date range:

The last

Sort by:

Sign up for:

Science Press Releases

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.